IBB

$IBB

As of 21 October 2026, 2 tracked analysts hold a current view on IBB: 1 Analyst Bullish · 0 Analysts Neutral · 1 Analyst Bearish. Every view links to the analyst's own post or video moment.

Catch-Up

Generated 08:00 ET · 10 OCT

$IBB is framed as having absorbed Friday’s dip and regained footing, with the rebound seen as evidence that near-term upside remains intact. The key qualification is that the constructive read rests on renewed buying interest holding after the pullback.

At Generation 1 Analyst Bull · 0 Analysts Neutral · 0 Analysts Bear
Since Catch-Up 0 Analysts Bull · 0 Analysts Neutral · 0 Analysts Bear
Mix By Horizon
1 Week
1 Month
1 Year

A daily catch-up of talking heads, in fifteen minutes.

Sentiment Graph

Last 30 Days
Today
SENTIMENT GRAPH

Analyst Views on IBB

1 Analyst Bullish · 0 Analysts Neutral · 1 Analyst Bearish
Bullish 1
Editorial Representation of Keith McCullough Keith McCullough BULLISH Moderate
Week 15d

Biotech $IBB has rebounded from Friday’s dip, supporting continued near-term upside after the pullback and renewed buying interest.

Bearish 1
Editorial Representation of Brian Shannon Brian Shannon BEARISH Moderate
Month 25d

Biotechs remain vulnerable after a month of lower highs and lower lows, with a break below 152 potentially opening a move toward 148.

$IBB

Wordcloud

BiotechIBBBuyingContinuedDipFridayInterestNear-TermPullbackReboundedRenewedSupportingUpside

Direction By Day

08 OCT09 OCT10 OCT11 OCT12 OCT13 OCT14 OCT15 OCT16 OCT17 OCT18 OCT19 OCT20 OCT21 OCT
Keith Mccullough▲▲▲···········

Sentiment Heatmap

08 OCT09 OCT10 OCT11 OCT12 OCT13 OCT14 OCT15 OCT16 OCT17 OCT18 OCT19 OCT20 OCT21 OCT
Keith Mccullough▲▲▲···········